 |
|
 |
We are a privately held corporation with funding from many investors believing in our vision of introducing low-cost, ultra-high throughput genome sequencing device that will open the door to the reality of personalized medicine to all people. If you interested in hearing more details on our strategy and technology, please email .
|
|
 |
 |
 |
 |
|
 |
| |
|
|
